SeaCrest Wealth Management LLC Has $1.29 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

SeaCrest Wealth Management LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.4% during the first quarter, Holdings Channel.com reports. The institutional investor owned 2,470 shares of the healthcare conglomerate’s stock after selling 753 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,294,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the business. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the business’s stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now directly owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of the business’s stock in a transaction dated Friday, May 16th. The stock was acquired at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have recently commented on UNH. Piper Sandler decreased their target price on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a research report on Tuesday. TD Securities reissued a “hold” rating and set a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Bank of America downgraded UnitedHealth Group from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. Argus cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Finally, Truist Financial reiterated a “buy” rating and issued a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $428.43.

UnitedHealth Group Stock Performance

Shares of UNH opened at $303.24 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a 50-day moving average of $409.03 and a 200-day moving average of $484.21. The company has a market cap of $275.08 billion, a PE ratio of 19.56, a P/E/G ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the business posted $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a $2.21 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.92%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.